患者様やご家族など一般の方向け臨床・治癒情報サイト 臨床研究情報ポータルサイト

ENGLISH
×

情報をクリップできます

治験情報をこちらのホームページで一時的にクリップすることが出来ます。

海外の治験の状況「1」での検索結果

絞り込み

1245件の検索結果
  • 進捗状況
  • 試験名
  • 対象疾患名
  • 地域
  • 登録日
  •  
  • Not recruiting

  • A Study in Second Line Metastatic Colorectal Cancer
  • Colorectal Cancer;Colorectal Cancer;Colorectal Cancer;Colorectal Cancer
  • Argentina, Australia, Austria, Belgium, Brazil, Czech Republic, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Netherlands, Portugal, Puerto Rico, Romania, Slovenia, Spain, Sweden, Taiwan, United States
  • 2010-08-04
  • Authorised

  • Pembrolizumab as First Line Treatment in Subjects with Recurrent/Metastatic HNSCC.
  • Recurrent/metastatic head and neck squamous cell carcinoma. MedDRA version: 20.0 Level: PT Classification code 10071540 Term: Head and neck cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
  • Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
  • 2014-12-22
  • Not recruiting

  • Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
  • NSCLC
  • Argentina, Australia, Brazil, Bulgaria, Canada, Chile, Estonia, Germany, Greece, Hungary, India, Ireland, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, Slovakia, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, Venezuela
  • 2005-10-19
  • Authorised

  • First-line chemotherapy plus pembrolizumab and olaparib for BRCA non-mutated advanced EOC
  • Advanced epithelial ovarian cancer MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
  • Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
  • 2018-10-23